FDA approves Keytruda for skin cancer patients with inoperable melanoma
Keytruda was granted special Food and Drug Administration clearance last month to be given to certain melanoma patients whose cancer worsens after standard treatment. The drug performed so well early in clinical trials that approval was granted before ...
Tampabay.com - Sun, 26 Oct 2014 17:24

Kevin Nealon to Host Third Annual Celebrity Golf Classic to Benefit Melanoma ...
HOLLYWOOD, Calif., Oct. 30, 2014 /PRNewswire-USNewswire/ -- Actor and comedian Kevin Nealon will reprise his role as host of the annual Melanoma Research Foundation Celebrity Golf Classic on November 10th at the Lakeside Golf Club in Burbank, ...
PR Newswire (press release) - Thu, 30 Oct 2014 11:22



Merck Shares Slip On Missed Revenue Despite 'Breakthrough' Designation For ...
It's a morning of mixed news for pharmaceutical giant Merck: the company reported Monday that the FDA granted a breakthrough therapy designation for its Keytruda drug, a treatment for metastatic melanoma and non-small cell lung cancer. Yet despite this ...
Forbes - Mon, 27 Oct 2014 06:46

Merck & Co's cancer drug Keytruda gaining traction in US
PMLiVE - Mon, 27 Oct 2014 05:28

Merck shares slide after earnings decline
USA TODAY - Mon, 27 Oct 2014 06:49

Merck Announces New Breakthrough Therapy Designation for Lung Cancer
Drug Discovery & Development - Mon, 27 Oct 2014 11:51

Merck 3Q adjusted profit tops analysts' estimates
News On 6 - Mon, 27 Oct 2014 05:08

Merck's Drug Sales Fell In Third Quarter But Earnings Beat Expectations
International Business Times - Mon, 27 Oct 2014 08:53

Training the body to fight melanoma
The numbers are staggering. One person dies of melanoma every hour and one in fifty men and women will be diagnosed with melanoma at some point in their lifetime. Now a new experimental therapy is training the body's immune system to fight the disease ...
ABC30.com - Tue, 28 Oct 2014 00:52

Teen battles Stage 4 melanoma
HE IS JUST 17 YEARS OLD AND DIAGNOSED WITH STAGE FOUR MELANOMA. IT WAS JUST A MOLE THAT ANNOYED ME. STRIKES ANYONE AT ANY AGE. YOU THINK OF MELANOMA AS OLD PERSON'S CANCER. TONIGHT LOCAL TEEN SHARES ...
WDIV Detroit - Fri, 10 Oct 2014 21:07

Nine weeks of biochemotherapy effective for high-risk melanoma
Key clinical point: A 9-week course of biochemotherapy markedly improved relapse-free survival in high-risk melanoma, compared with standard-of-care 1-year treatment. Major finding: The median relapse-free survival was 4.0 years for multiagent ...
Skin and Allergy News Digital Network - Wed, 29 Oct 2014 09:07

Malignant Melanoma: KOL Insight
LONDON, Oct. 28, 2014 /PRNewswire/ -- Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why ...
MarketWatch - Tue, 28 Oct 2014 08:33



Melanoma Cells: A Fatal Attraction to LPA
Melanoma cells could be busy dividing and trying to escape the skin in search of a blood vessel through which to colonize other parts of our body. But how do they decide it's time to migrate from the skin? Is there some sort of “go” signal that makes ...
PLoS Blogs (blog) - Tue, 14 Oct 2014 11:20

Scientists find that fat molecule directs melanoma to spread
HealthCanal.com - Wed, 15 Oct 2014 03:52

Melanoma cells create own 'green light' signal to spread in the body
News-Medical.net - Wed, 15 Oct 2014 02:40

A Chemical 'Breadcrumb Trail' Helps Melanoma Spread
Scicasts (press release) (registration) (blog) - Tue, 14 Oct 2014 13:26


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014